Financials

  • Market Capitalization 284.55 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.14
Rapporto prezzo/fatturato
26.03

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3286
EYPT
EyePoint, Inc. - Common Stock
3.34 USD-1.76%+5.36%-22.14%-72.17%287.95 M USD
3295
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.74 USD-0.80%+0.81%-2.09%-58.63%285.35 M USD
3305
ABEO
Abeona Therapeutics Inc. - Common Stock
4.93 USD-0.20%-3.71%-8.87%-9.21%281.92 M USD
3306
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
2.47 USD-3.52%-4.63%-24.92%-29.43%271.14 M USD

Notizie